IPOPLUS

₹22.85

▼ -0.39 -1.68%

12 Jun 2026

NSE Listed

Balaxi Pharmaceuticals Limited (BALAXI)

Volume: 34,058Avg Vol 1W: 30,008Avg Vol 1M: 29,556.952W Range:₹15.2₹54.7
NSE BSE
₹22.85▼ 1.68%
Key Ratios
Updated 3h ago
Market Cap₹126 Cr
Current Price₹22.85
Previous Close₹23.24
High / Low (52w)₹54.7 / ₹15.2
Volume34,058
Avg Vol (1W)30,008
Avg Vol (1M)29,556.9
Stock P/E207.73
Book Value₹45.12
Dividend Yield0%
ROE0.6%
ROA0.4%
Revenue (TTM)₹295 Cr
Revenue Growth21.3%
Profit Margin0.5%
Total Debt₹21 Cr
Shares Outstanding6 Cr
Face Value₹2
EPS (TTM)₹0.11
P/B0.51
Debt / Equity0.23
50 DMA₹25.38
200 DMA₹30.88
Day change-1.68%
Price Chart
₹22.85▼ 54.22% · 1Y
₹51₹1618.5L
2025-06-17
2026-06-12

20-day avg volume: 30K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 80% YoY.
  • Stock trades at a high P/E of 208.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹66 Cr₹77 Cr₹73 Cr₹76 Cr₹71 Cr₹56 Cr₹73 Cr₹71 Cr
EBITDA₹8 Cr₹6 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr
Net Profit₹6 Cr₹5 Cr₹5 Cr₹9 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹46 Cr₹234 Cr₹284 Cr₹339 Cr₹242 Cr₹295 Cr
EBITDA₹9 Cr₹44 Cr₹55 Cr₹57 Cr₹42 Cr₹32 Cr
Net Profit₹6 Cr₹38 Cr₹48 Cr₹46 Cr₹-2 Cr₹25 Cr
EPS——————
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹36 Cr₹100 Cr₹176 Cr₹240 Cr₹258 Cr₹310 Cr
Total Liabilities₹8 Cr₹35 Cr₹63 Cr₹57 Cr₹57 Cr₹79 Cr
Equity₹28 Cr₹65 Cr₹113 Cr₹183 Cr₹201 Cr₹232 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹21 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-13 Cr₹3 Cr₹40 Cr₹18 Cr₹12 Cr₹-32 Cr
Investing₹0 Cr₹-6 Cr₹-28 Cr₹-11 Cr₹-1 Cr₹-22 Cr
Financing₹18 Cr₹4 Cr₹0 Cr₹26 Cr₹30 Cr₹34 Cr
Free Cash Flow₹-13 Cr₹3 Cr₹40 Cr₹16 Cr₹12 Cr₹-32 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search